![]() In addition, often only one or maybe two doses are marketed initially. For newly marketed medications, we suggest starting with half or even one-quarter the lowest available dose, because dose–response studies have either not been done or their findings have not been incorporated into the product monograph. We are suggesting that it is reasonable in many cases to start with half the lowest marketed dose for older, established products. ![]() Unfortunately, this approach is not used that much in practice.įirst, we should define “very low dose.” The “start low, go slow” approach when starting medications - which entails starting with the lowest available dose - is generally well accepted in the medical community, especially for elderly patients. ![]() 1 The approach we recommend is to use a very low dose when starting a new medication if the condition is not life-threatening or producing severe symptoms. For years, we and others have advocated starting treatment of chronic indolent conditions at doses lower than those typically recommended in the product monographs.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |